脂类硫氧化物聚合物作为潜在的可吸入药物递送平台,具有差异性的专蛋白结合亲和力
Gayathri R Ediriweera1, Neville J Butcher2, Ashok Kothapalli2
1Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia. a.whittaker@uq.edu.au.
Biomaterials science
|April 29, 2024
概括
新型的小脂化硫氧化聚合物 (PMSEA) 显示出作为呼吸道疾病的可吸入纳米药物的前景. 这些聚合物提供可调节的膜透性和良好的粘液透性,没有观察到细胞毒性,这表明有可能在肺部进行量身定制的药物输送.
科学领域:
- 纳米医学是一种纳米医学.
- 聚合物化学 聚合物化学
- 呼吸道药物输送 呼吸道药物输送
背景情况:
- 吸入纳米药物对于治疗呼吸系统疾病至关重要,但目前的大型基于脂质的系统存在局限性.
- 聚二甲基硫乙烯酸 (PMSEA) 由于其隐形性质,具有作为一种新型纳米医学平台的潜力.
研究的目的:
- 研究新型的小型脂化硫氧化物聚合物 (PMSEA) 作为可吸入药物递送平台.
- 通过差异性白蛋白结合动力学来探索可调节的膜透性.
主要方法:
- 合成的线性PMSEA (5kDa) 与终端脂质 (1C2,1C12,2C12) 对于不同的专亲和力.
- 在试验室中评估了蛋白结合动力学,细胞毒性,粘液透,细胞吸收和透性.
主要成果:
- 在24小时内,PMSEA聚合物表现出良好的粘液透性和没有细胞毒性.
- 专辑蛋白结合亲和力有所不同:1C12-PMSEA (Kd ≈ 76 μM) 和2C12-PMSEA (Kd ≈ 10 μM).
- 2C12-PMSEA显示细胞吸收和透率降低,对这些参数的白蛋白影响最小.
结论:
- PMSEA聚合物显示出作为可调节性质的可吸入纳米药物的潜力.
- 脂质成分修饰可以控制膜透性和细胞相互作用,以优化肺部药物处置.
相关概念视频
Drug Distribution: Plasma Protein Binding
5.5K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.5K
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
202
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
202
Factors Affecting Protein-Drug Binding: Protein-Related Factors
156
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
156
Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH
1.3K
Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles...
1.3K
Non-Oral Extravascular Drug Absorption Routes
214
Non-oral extravascular routes, which encompass sublingual, buccal, topical, intramuscular, and inhalation methods, primarily utilize passive diffusion to transport drugs into the systemic circulation. The absorption rates and effectiveness of these routes depend on the drug's physicochemical properties, as well as the patient's anatomical and pathophysiological state.
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
Lipophilic drugs that are stable at salivary pH (6) and exhibit minimal binding to the oral mucosa are absorbed more...
214


